HCV REINFECTION AFTER SUCCESSFUL TREATMENT WITH DIRECT-ACTING ANTIVIRAL THERAPY (DAA) IN PEOPLE WHO INJECT DRUGS (PWID)

被引:0
|
作者
Patsi, Marina
Koustenis, Kanellos-Rafail
Kranidioti, Hariklia
Fylaktos, Panagiotis
Vasileiadi, Sofia
Antonakaki, Pinelopi
Koutli, Evangelia
Deutsch, Melanie
Anagnostou, Olga
Manolakopoulos, Spilios
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa323
引用
收藏
页码:S825 / S825
页数:1
相关论文
共 50 条
  • [1] HCV direct-acting antiviral therapy adherence in people who inject drugs
    Jordan Hindson
    [J]. Nature Reviews Gastroenterology & Hepatology, 2024, 21 : 141 - 141
  • [2] HCV direct-acting antiviral therapy adherence in people who inject drugs
    Hindson, Jordan
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (03) : 141 - 141
  • [3] ADHERENCE TO FOLLOW-UP OF PEOPLE WHO INJECT DRUGS (PWID) AFTER THE SUCCESSFUL TREATMENT OF CHRONIC HEPATITIS C WITH DIRECT-ACTING ANTIVIRALS (DAA)
    Koustenis, Kanellos-Rafail
    Koutli, Evangelia
    Kranidioti, Hariklia
    Antonakaki, Pinelopi
    Pantsas, Paris
    Anagnostou, Olga
    Deutsch, Melanie
    Manolakopoulos, Spilios
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1346 - S1346
  • [4] Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
    Cunningham, Evan B.
    Hajarizadeh, Behzad
    Amin, Janaki
    Hellard, Margaret
    Bruneau, Julie
    Feld, Jordan J.
    Cooper, Curtis
    Powis, Jeff
    Litwin, Alain H.
    Marks, Philippa
    Dalgard, Olav
    Conway, Brian
    Moriggia, Alberto
    Stedman, Catherine
    Read, Phillip
    Bruggmann, Philip
    Lacombe, Karine
    Dunlop, Adrian
    Applegate, Tanya L.
    Matthews, Gail, V
    Fraser, Chris
    Dore, Gregory J.
    Grebely, Jason
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (08) : 1392 - 1400
  • [5] Direct-acting antiviral agents for HCV infection affecting people who inject drugs
    Grebely, Jason
    Hajarizadeh, Behzad
    Dore, Gregory J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (11) : 641 - 651
  • [6] Direct-acting antiviral agents for HCV infection affecting people who inject drugs
    Jason Grebely
    Behzad Hajarizadeh
    Gregory J. Dore
    [J]. Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 641 - 651
  • [7] Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
    Minosse, Claudia
    Gruber, Cesare E. M.
    Rueca, Martina
    Taibi, Chiara
    Zaccarelli, Mauro
    Grilli, Elisabetta
    Montalbano, Marzia
    Capobianchi, Maria R.
    Antinori, Andrea
    D'Offizi, Gianpiero
    McPhee, Fiona
    Garbuglia, Anna Rosa
    [J]. VIRUSES-BASEL, 2021, 13 (06):
  • [8] Uptake of HCV treatment among people who inject drugs in the direct-acting antiviral era in a Canadian setting
    Socias, M. E.
    Ti, L.
    Wood, E.
    Nosova, E.
    Hull, M.
    Hayashi, K.
    Debeck, K.
    Milloy, M-J.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 383 - 383
  • [9] Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy
    Akiyama, Matthew J.
    Lipsey, Daniel
    Heo, Moonseong
    Agyemang, Linda
    Norton, Brianna L.
    Hidalgo, Jennifer
    Lora, Kiara
    Litwin, Alain H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (12) : 2695 - 2702
  • [10] Hepatitis C virus reinfection after successful treatment with all-oral, direct-acting antiviral therapy in a large population-based cohort including people who inject drugs
    Rossi, C.
    Islam, N.
    Alvarez, M.
    Chapinal, N.
    Darvishian, M.
    Samji, H.
    Butt, Z.
    Wong, S.
    Tyndall, M.
    Krajden, M.
    Janjua, N.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 137 - 138